FDA approves new ALS drug that costs $158,000 a year By: MarketWatch September 30, 2022 at 13:12 PM EDT Amylyx's new treatment for amyotrophic lateral sclerosis received funding raised during 2014's Ice Bucket Challenge. Read More >> Related Stocks: Amylyx Pharmaceuticals, Inc. - Common Stock
